(Q34462586)

2 August 2017

1 reference

title

Paclitaxel-based combination chemotherapy in advanced non-small cell lung cancer (English)

1 reference

2 August 2017

1 reference

1 reference

Greco FA

1

1 reference

2 August 2017

1 December 2001

1 reference

2 August 2017

1 reference

2 August 2017

34 Suppl 4

1 reference

2 August 2017

S53-6

1 reference

Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

Induction chemotherapy before surgery for early-stage lung cancer: A novel approach

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2801%2900393-2

7 January 2021

10.1016/S0169-5002(01)00393-2

Identifiers

DOI

1 reference

release_i6dllslgojgpzaa4evnkzfqhny

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/i6dllslgojgpzaa4evnkzfqhny

24 November 2022

mapped directly with Wikidata item

PubMed ID

11742703

1 reference

PubMed ID

11742703